Concepedia
Statistics
Publications
11
Citations
980
H-Index
Active since
1999
Affiliations
University of Bern(Current)
University Hospital of Bern
University of California San Diego
Heidelberg University
University of Lübeck
Vreni Schneider is an author at University of Bern specializing in liver disease, medicine, and pharmacology.
Publications per year
1999–2015
Pharmacological inhibition of integrin αvβ3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis #
Eleonora Patsenker, Yury Popov, Felix Stickel et al. · Hepatology · 2009 · 175 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +17
Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis
Markus Neef, M Ledermann, H. Saegesser et al. · Journal of Hepatology · 2006 · 142 citations
Pharmacy, Pharmacology, Pharmacotherapy +9
Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis
Eleonora Patsenker, Vreni Schneider, M Ledermann et al. · Journal of Hepatology · 2010 · 122 citations
Medicine, Pharmacology, Pharmacotherapy +15
Genetic variants of the TbAT1 adenosine transporter from African trypanosomes in relapse infections following melarsoprol therapy
Enock Matovu, Federico Geiser, Vreni Schneider et al. · Molecular and Biochemical Parasitology · 2001 · 101 citations
Life Sciences, Genetics, Molecular Genetics +12
Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term
Markus Neef, M Ledermann, H. Saegesser et al. · Journal of Hepatology · 2005 · 92 citations
Veterinary Medicine, Molecular Biology, Carcinogenesis +4
1–5 of 11